<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00560521</url>
  </required_header>
  <id_info>
    <org_study_id>Oliveira-1</org_study_id>
    <nct_id>NCT00560521</nct_id>
  </id_info>
  <brief_title>Continuous Positive Airway Pressure on Tuberculosis Pleural Effusion</brief_title>
  <official_title>Effect of Continuous Positive Airway Pressure on Fluid Absorption Among Patients With Pleural Effusion Due to Tuberculosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade Federal do Rio de Janeiro</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidade Federal do Rio de Janeiro</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tuberculosis (TB) remains as an important public health problem worldwide. Pleural
      tuberculosis is the most prevalent form of extrapulmonary presentation in immunocompetent
      patients.

      The volume of effusion in the pleural space of patients with pleural TB may cause
      complications like restrictive ventilator lung functional disturb and/or pleural thickening.
      The respiratory physiotherapy can be adjuvant on treatment of pleural effusion tuberculosis
      throughout of various treatment technique.

      The Continuous positive airway pressure (CPAP) is utilized in various pathologic, this
      improves lung mechanics by recruiting atelectatic alveoli, improving pulmonary compliance,
      and reducing the work of breathing.

      The aim of this study is to determine the effect of CPAP on fluid absorption among patients
      with pleural effusion due tuberculosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This randomized and controlled trial compared the reduction of the pleural effusion volume of
      the group of patients using the anti-TB standard regimen to that using the anti-TB standard
      regimen AND adjuvant treatment of physical therapy during four weeks.

        -  Control group: The patients received rifampicin, isoniazid and pyrazinamide
           daily(anti-TB standard regimen)

        -  Interventional group: The patients received anti-tb standard regime and Continuous
           Positive Airway Pressure (CPAP) 3 times a week for 30 minutes with positive expiratory
           end pressure of 10 cmH2O.

      Evaluation of the pleural effusion size: a helicoidal thoracic computed tomography (CT) was
      carried out in all patients enrolled. The valuation was conducted by two radiologists blinded
      for the treatment used, specifically trained for the purpose of the study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2005</start_date>
  <completion_date type="Actual">March 2007</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate of pleural effusion volume</measure>
    <time_frame>one month</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Tuberculosis</condition>
  <condition>Pleural Effusion</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>CPAP</intervention_name>
    <description>Frequency of three times a week, using a positive end expiratory pressure (PEEP) of 10 mmH2O for 30 minutes for four weeks.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Confirmed diagnosis of pleural tuberculosis.

          -  Patients 18 years of age and older.

        Exclusion criteria:

          -  Be under previous treatment of respiratory physiotherapy.

          -  Irregular use or abandonment of the anti-TB standard regimen.

          -  To fail one or more physiotherapy section.

          -  To fail one or more radiological evaluation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juliana F Oliveira, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidade Federal do Rio de Janeiro</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marcus B. Conde, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidade Federal do Rio de Janeiro</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rosana S. Rodrigues, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Universidade Federal do Rio de Janeiro</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sara L. Menezes, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidade Federal do Rio de Janeiro</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ana L. Boechat, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Universidade Federal do Rio de Janeiro</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fernanda C. Mello, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidade Federal do Rio de Janeiro</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clementino Fraga Filho University Hospital- Federal University of Rio de Janeiro</name>
      <address>
        <city>Rio de Janeiro</city>
        <zip>21941913</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Valdés L, Alvarez D, San José E, Penela P, Valle JM, García-Pazos JM, Suárez J, Pose A. Tuberculous pleurisy: a study of 254 patients. Arch Intern Med. 1998 Oct 12;158(18):2017-21.</citation>
    <PMID>9778201</PMID>
  </reference>
  <reference>
    <citation>Masip J. Non-invasive ventilation. Heart Fail Rev. 2007 Jun;12(2):119-24. Review.</citation>
    <PMID>17492379</PMID>
  </reference>
  <reference>
    <citation>Seiscento M, Conde MB, Dalcolmo MM. [Tuberculous pleural effusions]. J Bras Pneumol. 2006;32 Suppl 4:S174-81. Portuguese.</citation>
    <PMID>17273621</PMID>
  </reference>
  <reference>
    <citation>Conde MB, Loivos AC, Rezende VM, Soares SL, Mello FC, Reingold AL, Daley CL, Kritski AL. Yield of sputum induction in the diagnosis of pleural tuberculosis. Am J Respir Crit Care Med. 2003 Mar 1;167(5):723-5.</citation>
    <PMID>12598215</PMID>
  </reference>
  <results_reference>
    <citation>Vandevenne A, Moyses B, Weitzenblum E, Carloz I, Methlin G. [Regional pulmonary function in unilateral sero-fibrinous pleural effusions and changes under the influence of treatment (author's transl)]. Poumon Coeur. 1981;37(3):223-8. French.</citation>
    <PMID>7301718</PMID>
  </results_reference>
  <results_reference>
    <citation>Ferrer J. Pleural tuberculosis. Eur Respir J. 1997 Apr;10(4):942-7. Review.</citation>
    <PMID>9150338</PMID>
  </results_reference>
  <results_reference>
    <citation>Zhou A, Guo L, Tang L. Effect of an intrathoracic injection of sodium hyaluronic acid on the prevention of pleural thickening in excess fluid of tuberculous thoracic cavity. Clin Exp Pharmacol Physiol. 2003 Mar;30(3):203-5.</citation>
    <PMID>12603352</PMID>
  </results_reference>
  <verification_date>November 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 16, 2007</study_first_submitted>
  <study_first_submitted_qc>November 16, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 19, 2007</study_first_posted>
  <last_update_submitted>November 16, 2007</last_update_submitted>
  <last_update_submitted_qc>November 16, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2007</last_update_posted>
  <keyword>CPAP</keyword>
  <keyword>Tuberculosis</keyword>
  <keyword>Pleural effusion</keyword>
  <keyword>Physiotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
    <mesh_term>Pleural Effusion</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

